451 related articles for article (PubMed ID: 35280777)
1. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
Jyotsana N; Ta KT; DelGiorno KE
Front Oncol; 2022; 12():858462. PubMed ID: 35280777
[TBL] [Abstract][Full Text] [Related]
2. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
3. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
Koppula P; Zhang Y; Zhuang L; Gan B
Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
[TBL] [Abstract][Full Text] [Related]
4. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin W; Wang C; Liu G; Bi C; Wang X; Zhou Q; Jin H
Am J Cancer Res; 2020; 10(10):3106-3126. PubMed ID: 33163260
[TBL] [Abstract][Full Text] [Related]
6. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
7. A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options.
Criscuolo D; Morra F; Celetti A
Explor Target Antitumor Ther; 2022; 3(5):570-581. PubMed ID: 36338517
[TBL] [Abstract][Full Text] [Related]
8. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P; Zhang Y; Shi J; Li W; Gan B
J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
Banerjee S; Sarkar R; Mukherjee A; Mitra S; Gope A; Chawla-Sarkar M
Virus Res; 2024 Jan; 339():199261. PubMed ID: 37923170
[TBL] [Abstract][Full Text] [Related]
10. SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer.
Lee J; Roh JL
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552652
[TBL] [Abstract][Full Text] [Related]
11. Role of SLC7A11/xCT in Ovarian Cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract][Full Text] [Related]
12. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.
Liu J; Xia X; Huang P
Mol Ther; 2020 Nov; 28(11):2358-2366. PubMed ID: 32931751
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity.
Tan SLW; Tan HM; Israeli E; Fatihah I; Ramachandran V; Ali SB; Goh SJA; Wee J; Tan AQL; Tam WL; Han W
Biochem J; 2023 Dec; 480(24):2045-2058. PubMed ID: 38078799
[TBL] [Abstract][Full Text] [Related]
14. Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses.
Daher B; Parks SK; Durivault J; Cormerais Y; Baidarjad H; Tambutte E; Pouysségur J; Vučetić M
Cancer Res; 2019 Aug; 79(15):3877-3890. PubMed ID: 31175120
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma.
Wang HH; Fan SQ; Zhan YT; Peng SP; Wang WY
Int J Biol Macromol; 2024 Jan; 254(Pt 3):127976. PubMed ID: 37951442
[TBL] [Abstract][Full Text] [Related]
16. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
17. Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.
Ruiu R; Cossu C; Iacoviello A; Conti L; Bolli E; Ponzone L; Magri J; Rumandla A; Calautti E; Cavallo F
J Exp Clin Cancer Res; 2023 Sep; 42(1):254. PubMed ID: 37770957
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11.
Martin L; Gardner LB
Oncogene; 2015 Aug; 34(32):4211-8. PubMed ID: 25399695
[TBL] [Abstract][Full Text] [Related]
19. Disulfidptosis: disulfide stress-induced cell death.
Liu X; Zhuang L; Gan B
Trends Cell Biol; 2024 Apr; 34(4):327-337. PubMed ID: 37574347
[TBL] [Abstract][Full Text] [Related]
20. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo.
Chen H; Cao L; Han K; Zhang H; Cui J; Ma X; Zhao S; Zhao C; Yin S; Fan L; Hu H
Food Chem Toxicol; 2022 Aug; 166():113255. PubMed ID: 35772596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
